IQVIA HOLDINGS INC.·4

Feb 11, 5:06 PM ET

GOGGINS COLLEEN A 4

4 · IQVIA HOLDINGS INC. · Filed Feb 11, 2026

Research Summary

AI-generated summary of this filing

Updated

IQVIA Director Colleen Goggins Receives 198-Share Award

What Happened
Colleen A. Goggins, a director of IQVIA Holdings Inc. (IQV), was awarded 198 deferred shares on February 9, 2026. The award is recorded at $192.67 per share, for a total value of $38,149. The transaction is coded as an award/acquisition (A) and is reported as a derivative grant (deferred shares).

Key Details

  • Transaction date: 2026-02-09; reported on Form 4 filed 2026-02-11 (appears timely).
  • Award: 198 deferred shares at $192.67 each; total reported value $38,149.
  • Shares owned after transaction: not specified in the provided excerpt.
  • Footnote: Deferred shares are convertible into one share of IQV common stock upon settlement under the Non-Employee Director Deferral Plan. Settlement occurs when the director leaves the board, upon a change in control, or upon the director’s death; there is no expiry date.
  • Transaction type: Award (A); recorded as a derivative (not an immediate issuance of common stock).

Context
This was a routine director compensation grant (deferred share award). Deferred shares do not immediately increase tradable common stock—conversion happens only upon defined settlement events—so this is compensation-related rather than an open-market purchase or sale. Directors’ routine awards are standard corporate practice and should be viewed as compensation administration rather than a direct buy/sell signal.

Insider Transaction Report

Form 4
Period: 2026-02-09
Transactions
  • Award

    Deferred Shares

    [F1]
    2026-02-09$192.67/sh+198$38,1494,900 total
    Common Stock (198 underlying)
Footnotes (1)
  • [F1]Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.
Signature
/s/ Matthew Gilmartin, Attorney-in-Fact for Colleen A. Goggins|2026-02-11

Documents

1 file
  • 4
    wk-form4_1770847610.xmlPrimary

    FORM 4